Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Income Statement [Abstract]
Revenue		$ 3,900		$ 3,900
Cost of sales		1,520		1,520
Gross margin		2,380		2,380
Operating expenses:
Research and development	$ 1,198,965	757,303	$ 2,423,896	1,322,935
Selling, general and administrative	786,068	815,020	1,636,804	1,580,043
Total operating expenses	1,985,033	1,572,323	4,060,700	2,902,978
Loss from operations	(1,985,033)	(1,569,943)	(4,060,700)	(2,900,598)
Other income (expense)
Interest expense	(117,598)	(178,438)	(140,124)	(214,698)
Other income	19,713	3	66,217	63
Total other expense	(97,885)	(178,435)	(73,907)	(214,635)
Net loss	$ (2,082,918)	$ (1,748,378)	$ (4,134,607)	$ (3,115,233)
Net loss per share, basic	$ (2.27)	$ (15.92)	$ (4.88)	$ (29.23)
Net loss per share, diluted	$ (2.27)	$ (15.92)	$ (4.88)	$ (29.23)
Weighted average common shares outstanding, basic	917,445	109,841	847,990	106,582
Weighted average common shares outstanding, diluted	917,445	109,841	847,990	106,582